These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 14031335)
1. Frontiers in measles prophylaxis. KATZ SL N Y State J Med; 1963 Feb; 63():377-81. PubMed ID: 14031335 [No Abstract] [Full Text] [Related]
2. [THE PROBLEM OF SPECIFIC PROPHYLAXIS AGAINST THE MAJOR VIRAL DISEASES]. BAROIAN OB Vestn Akad Med Nauk SSSR; 1963; 18():36-45. PubMed ID: 14067306 [No Abstract] [Full Text] [Related]
3. Development of measles vaccines in Japan. Ueda S Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
5. Do childhood vaccines have non-specific effects on mortality? Cooper WO; Boyce TG; Wright PF; Griffin MR Bull World Health Organ; 2003; 81(11):821-6. PubMed ID: 14758409 [TBL] [Abstract][Full Text] [Related]
6. The effectiveness of prophylaxis for measles contacts in NSW. Sheppeard V; Forssman B; Ferson MJ; Moreira C; Campbell-Lloyd S; Dwyer DE; McAnulty JM N S W Public Health Bull; 2009; 20(5-6):81-5. PubMed ID: 19552854 [TBL] [Abstract][Full Text] [Related]
7. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003. Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK; Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204 [TBL] [Abstract][Full Text] [Related]
8. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Brandler S; Tangy F Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines. Tillieux SL; Halsey WS; Sathe GM; Vassilev V Vaccine; 2009 Apr; 27(16):2265-73. PubMed ID: 19428841 [TBL] [Abstract][Full Text] [Related]
10. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children. Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583 [TBL] [Abstract][Full Text] [Related]
11. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay. Schalk JA; de Vries CG; Jongen PM Biologicals; 2005 Jun; 33(2):71-9. PubMed ID: 15939284 [TBL] [Abstract][Full Text] [Related]
12. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051 [TBL] [Abstract][Full Text] [Related]
13. Measles: immune suppression and immune responses. Moss WJ; Ota MO; Griffin DE Int J Biochem Cell Biol; 2004 Aug; 36(8):1380-5. PubMed ID: 15147716 [TBL] [Abstract][Full Text] [Related]
14. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques. Pasetti MF; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams RJ; Polack FP; Ward BJ; Burt D; Chabot S; Ulmer J; Barry EM; Levine MM Clin Pharmacol Ther; 2007 Dec; 82(6):672-85. PubMed ID: 17971812 [TBL] [Abstract][Full Text] [Related]